Prevalence of hypertension, male in North America
North America: Prevalence of hypertension, male was 33.1% in 2019. ▬ Flat
Prevalence of hypertension, male in North America, 1990–2019
Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of male adults ages 30-79.
Analysis
The most recent figure for prevalence of hypertension, male in North America is 33.1%, measured in 2019.
That represents a change of up 0.2% on the previous year and up 0.1% over ten years.
Over the whole period, prevalence of hypertension, male in North America peaked at 33.3% in 1990 and was at its lowest, 32.6%, in 2000.
That places North America 33rd out of 43 groups with data for 2019, putting it in the bottom quarter.
Prevalence of hypertension, male in North America, year by year
| Year | % of male adults ages 30-79 | Change |
|---|---|---|
| 1990 | 33.3% | — |
| 1991 | 33.2% | -0.2% |
| 1992 | 33.2% | -0.2% |
| 1993 | 33.1% | -0.2% |
| 1994 | 33.0% | -0.2% |
| 1995 | 32.9% | -0.5% |
| 1996 | 32.8% | -0.2% |
| 1997 | 32.8% | -0.2% |
| 1998 | 32.7% | -0.2% |
| 1999 | 32.7% | -0.2% |
| 2000 | 32.6% | -0.2% |
| 2001 | 32.6% | +0.1% |
| 2002 | 32.7% | +0.1% |
| 2003 | 32.7% | +0.1% |
| 2004 | 32.8% | +0.1% |
| 2005 | 32.8% | +0.1% |
| 2006 | 32.9% | +0.4% |
| 2007 | 33.0% | +0.2% |
| 2008 | 33.0% | -0.1% |
| 2009 | 33.0% | +0.2% |
| 2010 | 33.0% | -0.1% |
| 2011 | 32.9% | -0.1% |
| 2012 | 32.9% | -0.1% |
| 2013 | 32.9% | -0.1% |
| 2014 | 32.9% | -0.1% |
| 2015 | 32.9% | +0.2% |
| 2016 | 32.9% | -0.1% |
| 2017 | 32.9% | +0.2% |
| 2018 | 33.0% | +0.2% |
| 2019 | 33.1% | +0.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 33.0% | 32.7% | 33.3% | 10 |
| 2000s | 32.8% | 32.6% | 33.0% | 10 |
| 2010s | 32.9% | 32.9% | 33.1% | 10 |
Countries ranked near North America
More health data for North America
- Population ages 55-59, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0297 units per person (2025)
- Population ages 55-59, male, annual growth rate -0.5946 % change on previous year (2025)
- Population ages 15-19, female, per capita 0.0314 units per person (2025)
- Population ages 60-64, female, annual growth rate -0.6806 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, annual growth rate 0.3175 % change on previous year (2025)
- Population ages 55-59, male, per capita 0.0301 units per person (2025)
Frequently asked questions
- What is prevalence of hypertension, male in North America?
- Prevalence of hypertension, male in North America was 33.1% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
- What is the highest prevalence of hypertension, male recorded in North America?
- The highest recorded value was 33.3% in 1990.
- What is the lowest prevalence of hypertension, male recorded in North America?
- The lowest recorded value was 32.6% in 2000.
- How does North America rank for prevalence of hypertension, male?
- North America ranks 33rd out of 43 groups with data for 2019.
- Is prevalence of hypertension, male rising or falling in North America?
- Over the last ten years it is up 0.1%. The long-run trend across the full record is flat.
- Where does this North America data come from?
- The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Prevalence of hypertension, male (% of male adults ages 30-79). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Prevalence of hypertension, male, is the percentage of male adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.